Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Etoposide (VP-16-213).

× No keyword cloud information.

35 in total

1. Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer.

Authors: K Shibata; Y Nakatsumi; K Kasahara; T Bando; M Fujimura; T Matsuda
Journal: J Cancer Res Clin Oncol Date: 1996 Impact factor: 4.553

Review 2. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors: J M Henwood; R N Brogden
Journal: Drugs Date: 1990-03 Impact factor: 9.546

Review 3. The podophyllotoxin derivatives VP16-213 and VM26.

Authors: B F Issell
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 4. Current development of podophyllotoxins.

Authors: R Canetta; P Hilgard; S Florentine; P Bedogni; L Lenaz
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 5. VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.

Authors: J D Loike
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 6. Cancer chemotherapy: past, present, and future--Part I.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1984-08 Impact factor: 1.798

7. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.

Authors: B F Issell; C Tihon; M E Curry
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

8. Pharmacokinetics of VP16-213 given by different administration methods.

Authors: M D'Incalci; P Farina; C Sessa; C Mangioni; V Conter; G Masera; M Rocchetti; M B Pisoni; E Piazza; M Beer; F Cavalli
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

9. Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

Authors: F C Schell; H Y Yap; G N Hortobagyi; B Issell; L Esparza
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

10. Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice.

Authors: T Colombo; M Broggini; L Torti; E Erba; M D'Incalci
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333